Interestingly, an association between Nppa promoter polymorphism and cardiac hypertrophy has been demonstrated in hypertensive Italian patients, suggesting that patients carrying SNPs of Nppa have marked decreases in pro-ANP levels and left ventricular hypertrophy [147]. This evidence concerns the gene NPPA and left ventricular hypertrophy.